Jiwei Ma

592 total citations
28 papers, 476 citations indexed

About

Jiwei Ma is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jiwei Ma has authored 28 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Jiwei Ma's work include MicroRNA in disease regulation (5 papers), Cancer Cells and Metastasis (4 papers) and Glioma Diagnosis and Treatment (3 papers). Jiwei Ma is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer Cells and Metastasis (4 papers) and Glioma Diagnosis and Treatment (3 papers). Jiwei Ma collaborates with scholars based in China, United States and Japan. Jiwei Ma's co-authors include Xueyun Zhong, Haiying Li, Shaoxiang Wang, Yong Zhang, Siming Xie, Bin Du, Ru Li, Xiaoyan Fu, Wenqiang Cao and Xueqi Fu and has published in prestigious journals such as Biochemical Pharmacology, Experimental Cell Research and European Journal of Pharmacology.

In The Last Decade

Jiwei Ma

26 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiwei Ma China 14 232 99 92 59 51 28 476
Bong Jun Cho South Korea 14 324 1.4× 112 1.1× 106 1.2× 62 1.1× 40 0.8× 19 610
Yung‐Lung Chang Taiwan 15 360 1.6× 71 0.7× 104 1.1× 51 0.9× 47 0.9× 32 566
Tian‐Huei Chu Taiwan 16 348 1.5× 132 1.3× 172 1.9× 59 1.0× 25 0.5× 41 774
Vahid Vahedian Iran 14 320 1.4× 179 1.8× 127 1.4× 58 1.0× 21 0.4× 27 621
Ziwen Lu China 15 358 1.5× 73 0.7× 182 2.0× 62 1.1× 67 1.3× 50 661
Guangjie Sui China 10 196 0.8× 108 1.1× 43 0.5× 53 0.9× 74 1.5× 18 419
Yakun Yang China 15 192 0.8× 85 0.9× 64 0.7× 45 0.8× 37 0.7× 46 590
Yanyang Wang China 11 431 1.9× 93 0.9× 88 1.0× 167 2.8× 35 0.7× 27 688
Yühong Huang China 10 521 2.2× 84 0.8× 152 1.7× 61 1.0× 93 1.8× 19 1.1k

Countries citing papers authored by Jiwei Ma

Since Specialization
Citations

This map shows the geographic impact of Jiwei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiwei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiwei Ma more than expected).

Fields of papers citing papers by Jiwei Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiwei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiwei Ma. The network helps show where Jiwei Ma may publish in the future.

Co-authorship network of co-authors of Jiwei Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Jiwei Ma. A scholar is included among the top collaborators of Jiwei Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiwei Ma. Jiwei Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Zhou & Jiwei Ma. (2024). Case report: Rare case of multinodular and vacuolar neuronal tumors in the cerebellum. Frontiers in Neurology. 14. 1309209–1309209. 3 indexed citations
3.
Zhu, Xuqiang, Di Chen, Shuo Yang, et al.. (2023). LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma. BMC Cancer. 23(1). 120–120. 5 indexed citations
4.
Yao, Zhigang, et al.. (2022). Bone marrow-derived mesenchymal stem cells expressing BMP2 suppress glioma stem cell growth and stemness through Bcl-2/Bax signaling. Journal of Cancer Research and Therapeutics. 18(7). 2033–2040. 6 indexed citations
5.
Wei, Zhigang, Xia Yang, Yan Feng, et al.. (2021). Could concurrent biopsy and microwave ablation be reliable? Concordance between frozen section examination and final pathology in CT-guided biopsy of lung cancer. International Journal of Hyperthermia. 38(1). 1031–1036. 6 indexed citations
6.
Ma, Jiwei, et al.. (2020). CREB1-induced miR-1204 promoted malignant phenotype of glioblastoma through targeting NR3C2. Cancer Cell International. 20(1). 111–111. 16 indexed citations
7.
8.
Ma, Xiaochun, Jinzhang Li, Wei Dong, et al.. (2020). Transcatheter aortic valve implantation in the patients with chronic liver disease. Medicine. 99(16). e19766–e19766. 8 indexed citations
9.
Ma, Xiaochun, Jinzhang Li, Yan Yun, et al.. (2020). Endothelial-to-Mesenchymal Transition in Calcific Aortic Valve Disease.. PubMed. 36(3). 183–194. 38 indexed citations
10.
Yin, Zhiwei, et al.. (2019). Potential Association of Body Constitution with the Prognosis of IgA Nephropathy: A Long-Time Follow-Up of 203 Cases in China. Evidence-based Complementary and Alternative Medicine. 2019. 1–6. 8 indexed citations
11.
Cao, Wenqiang, Xiaoqian Zhai, Jiwei Ma, et al.. (2019). Natural borneol sensitizes human glioma cells to cisplatin-induced apoptosis by triggering ROS-mediated oxidative damage and regulation of MAPKs and PI3K/AKT pathway. Pharmaceutical Biology. 58(1). 72–79. 52 indexed citations
12.
Li, Yaqiong, Xinli Wang, Zhiyan Liu, et al.. (2019). Hashimoto's Thyroiditis with Increased IgG4-Positive Plasma Cells: Using Thyroid-Specific Diagnostic Criteria May Identify Early Phase IgG4 Thyroiditis. Thyroid. 30(2). 251–261. 17 indexed citations
13.
14.
Ma, Xiaochun, Zhenqiang Xu, Jinzhang Li, et al.. (2019). Antiplatelet strategy after transcatheter aortic valve replacement: an updated meta-analysis. The Journal of Cardiovascular Surgery. 60(5). 624–632. 2 indexed citations
15.
Ma, Jiwei, Xiao Wang, Xueyun Zhong, et al.. (2018). CD44 collaborates with ERBB2 mediate radiation resistance via p38 phosphorylation and DNA homologous recombination pathway in prostate cancer. Experimental Cell Research. 370(1). 58–67. 8 indexed citations
16.
Ma, Jiwei, et al.. (2015). Probucol Protects Against Asymmetric Dimethylarginine-Induced Apoptosis in the Cultured Human Brain Microvascular Endothelial Cells. Journal of Molecular Neuroscience. 57(4). 546–553. 23 indexed citations
17.
Wang, Shaoxiang, Xiao Wang, Haiying Li, et al.. (2015). Inhibition of heat shock protein 90 suppresses squamous carcinogenic progression in a mouse model of esophageal cancer. Journal of Cancer Research and Clinical Oncology. 141(8). 1405–1416. 13 indexed citations
18.
Ma, Jiwei, Yong Zhang, Ru Li, et al.. (2015). Tetrandrine suppresses human glioma growth by inhibiting cell survival, proliferation and tumour angiogenesis through attenuating STAT3 phosphorylation. European Journal of Pharmacology. 764. 228–239. 33 indexed citations
19.
Zhang, Yong, Shaoxiang Wang, Jiwei Ma, et al.. (2014). EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition. Journal of Neuro-Oncology. 121(1). 41–52. 83 indexed citations
20.
Gao, Guojun, et al.. (2014). Effects of ulinastatin on cerebral oxygen metabolism and CRP levels in patients with severe traumatic brain injury. Experimental and Therapeutic Medicine. 7(6). 1683–1686. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bong Jun Cho Breakdown of academic impact, for papers by Yung‐Lung Chang Breakdown of academic impact, for papers by Tian‐Huei Chu Breakdown of academic impact, for papers by Vahid Vahedian Breakdown of academic impact, for papers by Ziwen Lu Breakdown of academic impact, for papers by Guangjie Sui Breakdown of academic impact, for papers by Yakun Yang Breakdown of academic impact, for papers by Yanyang Wang Breakdown of academic impact, for papers by Yühong Huang
Rankless by CCL
2026